Lymphocyte Reconstitution in a Randomized Study After Administration of Pegfilgrastim Versus Filgrastim in Patients With B-cell Non-Hodgkin Lymphoma Treated With High-dose Chemotherapy and Autologous Peripheral Stem Cell Transplantation (PALM2)

NCT01541072 NA TERMINATED

The purpose of this study is to describe the kinetics of lymphocyte subsets reconstitution after growth factor administration, Pegfilgrastim versus Filgrastim in patients with B-cell malignant non-Hodgkin lymphoma treated with high-dose chemotherapy and autologous peripheral stem cell transplantation.

Details

Lead sponsor	Centre Leon Berard
Phase	NA
Status	TERMINATED
Enrolment	34
Start date	2012-02
Completion	2014-09

Conditions

• Non Hodgkin Lymphoma

Interventions

• Pegfilgrastim
• Filgrastim

Primary outcomes

• 3 months kinetics of lymphocyte reconstitution, in the two arms — Lymphocyte count within the 3 months post transplantation

Countries

France